Compound Detail
CHEMBL1944698
ZOTIRACICLIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1944698 |
| Name | ZOTIRACICLIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | VXBAJLGYBMTJCY-NSCUHMNNSA-N |
63
Targets
86
Activities
2
Assay Types
16
PK Parameters
20
Publications
8
Known Names
7
Indications
6
Mechanisms
Molecular Properties
372.5
MW (Da)
4.66
ALogP
5
HBA
1
HBD
50.3
PSA (Ų)
0.58
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclin-dependent kinase 1 inhibitor | INHIBITOR | Cyclin-dependent kinase 1 | ✓ | ✓ |
| Cyclin-dependent kinase 2 inhibitor | INHIBITOR | Cyclin-dependent kinase 2 | ✓ | ✓ |
| Cyclin-dependent kinase 7 inhibitor | INHIBITOR | Cyclin-dependent kinase 7 | ✓ | ✓ |
| Cyclin-dependent kinase 9 inhibitor | INHIBITOR | Cyclin-dependent kinase 9 | ✓ | ✓ |
| Tyrosine-protein kinase receptor FLT3 inhibitor | INHIBITOR | Receptor-type tyrosine-protein kinase FLT3 | ✓ | ✓ |
| Tyrosine-protein kinase JAK2 inhibitor | INHIBITOR | Tyrosine-protein kinase JAK2 | ✓ | ✓ |
Indications
Carcinoma, Hepatocellular Glioblastoma Gliosarcoma Hematologic Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Neoplasms Rectal Neoplasms
Activity Summary
Kd 47 meas. best 9.0
IC50 39 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 9 CHEMBL3116 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Cyclin-dependent kinase 9 CHEMBL3116 | IC50 | 8.7 | 8.61 | 2.0 | 2 |
| Cyclin-dependent kinase 5 CHEMBL4036 | IC50 | 8.52 | 8.46 | 3.0 | 2 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 8.52 | 7.9 | 3.0 | 4 |
| CDK3/Cyclin E CHEMBL3038471 | IC50 | 8.52 | 8.24 | 3.0 | 3 |
| CDK7/Cyclin H/MNAT1 CHEMBL3038473 | IC50 | 8.52 | 7.975 | 3.0 | 2 |
| CDK9/Cyclin K CHEMBL3038475 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Cyclin-dependent kinase 1 CHEMBL308 | IC50 | 8.52 | 8.285 | 3.0 | 2 |
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 8.05 | 8.05 | 9.0 | 1 |
| Cyclin-dependent kinase 2/cyclin A CHEMBL2094128 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 7.68 | 7.39 | 21.0 | 4 |
| AarF domain-containing protein kinase 1 CHEMBL4105885 | Kd | 7.64 | 7.64 | 23.0 | 1 |
| Ramos CHEMBL614629 | IC50 | 7.48 | 7.48 | 33.0 | 1 |
| Cyclin-dependent kinase 16 CHEMBL4597 | Kd | 7.46 | 7.46 | 35.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | IC50 | 7.43 | 7.43 | 37.0 | 1 |
| Mitogen-activated protein kinase 7 CHEMBL5332 | Kd | 7.37 | 7.37 | 43.0 | 1 |
| Mitogen-activated protein kinase 7 CHEMBL5332 | IC50 | 7.37 | 7.37 | 43.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 7.23 | 7.23 | 59.0 | 1 |
| COLO 205 CHEMBL614561 | IC50 | 7.14 | 7.14 | 72.0 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 7.14 | 7.066 | 73.0 | 5 |
| HCT-116 CHEMBL394 | IC50 | 7.1 | 7.1 | 79.0 | 1 |
| Serine/threonine-protein kinase N2 CHEMBL3032 | Kd | 6.85 | 6.85 | 141.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 6.85 | 6.85 | 140.0 | 1 |
| Ferrochelatase, mitochondrial CHEMBL3879831 | Kd | 6.61 | 6.61 | 243.0 | 1 |
| Cyclin-dependent kinase 2 CHEMBL301 | Kd | 6.61 | 6.61 | 243.0 | 1 |
| Interleukin-1 receptor-associated kinase 3 CHEMBL5081 | Kd | 6.54 | 6.54 | 286.0 | 1 |
| Serine/threonine-protein kinase 3 CHEMBL4708 | Kd | 6.51 | 6.51 | 311.0 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD CHEMBL4105743 | Kd | 6.5 | 6.5 | 319.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 6.38 | 6.38 | 418.0 | 1 |
| Glycogen synthase kinase-3 beta CHEMBL262 | Kd | 6.35 | 6.35 | 447.0 | 1 |
| Cyclin-dependent kinase 7 CHEMBL3055 | Kd | 6.33 | 6.33 | 473.0 | 1 |
| Serine/threonine-protein kinase D2 CHEMBL4900 | Kd | 6.32 | 6.32 | 474.0 | 1 |
| Serine/threonine-protein kinase D3 CHEMBL2595 | Kd | 6.25 | 6.25 | 557.0 | 1 |
| Glycogen synthase kinase-3 alpha CHEMBL2850 | Kd | 6.24 | 6.24 | 579.0 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 CHEMBL5432 | Kd | 6.07 | 6.07 | 850.0 | 1 |
| Protein kinase C alpha type CHEMBL299 | Kd | 6.05 | 6.05 | 885.0 | 1 |
| Cyclin-dependent kinase 5 CHEMBL4036 | Kd | 6.03 | 6.03 | 930.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 6.02 | 6.02 | 950.0 | 2 |
| Protein kinase C delta type CHEMBL2996 | Kd | 6.0 | 6.0 | 996.0 | 1 |
| Mitogen-activated protein kinase 15 CHEMBL5198 | Kd | 5.97 | 5.97 | 1073.0 | 1 |
| Serine/threonine-protein kinase TAO2 CHEMBL1075195 | Kd | 5.97 | 5.97 | 1070.0 | 1 |
| Serine/threonine-protein kinase SIK3 CHEMBL6149 | Kd | 5.89 | 5.89 | 1300.0 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 CHEMBL5330 | Kd | 5.87 | 5.87 | 1364.0 | 1 |
| Mitogen-activated protein kinase 8 CHEMBL2276 | Kd | 5.84 | 5.84 | 1457.0 | 1 |
| Cyclin-dependent kinase 6 CHEMBL2508 | Kd | 5.8 | 5.8 | 1597.0 | 1 |
| Serine/threonine-protein kinase N1 CHEMBL3384 | Kd | 5.77 | 5.77 | 1689.0 | 1 |
| Tyrosine-protein kinase Fer CHEMBL3982 | Kd | 5.77 | 5.77 | 1695.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 752.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2523.0 | ng.hr.mL-1 | Mus musculus |
| CL | 110.0 | mL.min-1.kg-1 | Mus musculus |
| Cmax | 2762.64 | nM | Mus musculus |
| F | 24.0 | % | Mus musculus |
| F | 4.0 | % | Rattus norvegicus |
| F | 37.0 | % | Canis lupus familiaris |
| T1/2 | 0.75 | hr | Homo sapiens |
| T1/2 | 0.2 | hr | Mus musculus |
| T1/2 | 0.1833 | hr | Rattus norvegicus |
| T1/2 | 0.55 | hr | Canis lupus familiaris |
| T1/2 | 4.6 | hr | Mus musculus |
| T1/2 | 6.1 | hr | Mus musculus |
| T1/2 | 0.75 | hr | Homo sapiens |
| T1/2 | 0.2 | hr | Mus musculus |
| Tmax | 0.5 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22148278 | 10.1021/jm201112g | Mus musculus | 9 |
| 22148278 | 10.1021/jm201112g | Cyclin-dependent kinase 2 | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| 22148278 | 10.1021/jm201112g | HCT-116 | 4 |
| 22148278 | 10.1021/jm201112g | Ramos | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22148278 | 10.1021/jm201112g | Plasma | 3 |
| 22148278 | 10.1021/jm201112g | Caco-2 | 3 |
| 38389874 | 10.1039/d3md00457k | ADMET | 3 |
| 22148278 | 10.1021/jm201112g | Liver microsomes | 2 |
| 22148278 | 10.1021/jm201112g | Liver | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37002872 | 10.1021/acs.jmedchem.3c00072 | Mitogen-activated protein kinase 7 | 2 |
| 22148278 | 10.1021/jm201112g | DU-145 | 1 |
| 38389874 | 10.1039/d3md00457k | Cyclin-dependent kinase 2 | 1 |
| 22148278 | 10.1021/jm201112g | Cytochrome P450 3A4 | 1 |
| 22148278 | 10.1021/jm201112g | HL-60 | 1 |
| 22148278 | 10.1021/jm201112g | No relevant target | 1 |
| 22148278 | 10.1021/jm201112g | Tyrosine-protein kinase JAK2 | 1 |
Data from ChEMBL 36 via Core Engine